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ABSTRACT: Photoacoustic imaging combines both excellent spatial
resolution with high contrast and speciﬁcity, without the need for
patients to be exposed to ionizing radiation. This makes it ideal for the
study of physiological changes occurring during tumorigenesis and
cardiovascular disease. In order to fully exploit the potential of this
technique, new exogenous contrast agents with strong absorbance in
the near-infrared range, good stability and biocompatibility, are
required. In this paper, we report the formulation and characterization
of a novel series of endogenous contrast agents for photoacoustic
imaging in vivo. These contrast agents are based on a recently reported
series of indigoid π-conjugated organic semiconductors, coformulated
with 1,2-dipalmitoyl-sn-glycero-3-phosphocholine, to give semicon-
ducting polymer nanoparticles of about 150 nm diameter. These
nanoparticles exhibited excellent absorption in the near-infrared region,
with good photoacoustic signal generation eﬃciencies, high photostability, and extinction coeﬃcients of up to three times higher
than those previously reported. The absorption maximum is conveniently located in the spectral region of low absorption of
chromophores within human tissue. Using the most promising semiconducting polymer nanoparticle, we have demonstrated
wavelength-dependent diﬀerential contrast between vasculature and the nanoparticles, which can be used to unambiguously
discriminate the presence of the contrast agent in vivo.
■ INTRODUCTION
Photoacoustic (PA) imaging is an emerging technique based on
the use of laser generated ultrasound, which holds great
promise for visualizing anatomical structures and physiological
changes in vivo. It combines the advantages of ultrasound
imaging (submillimeter spatial resolution with deep tissue
imaging penetration) with the high contrast and speciﬁcity of
optical imaging.1 It is noninvasive and does not require the use
of ionizing radiation, and has signiﬁcant potential for the
clinical and preclinical study of conditions such as breast, head
and neck, melanoma, colorectal, prostate, and ovarian cancers,
and cardiovascular disease.2 Endogenous PA image contrast is
based on optical absorption provided by naturally occurring
chromophores, such as lipids or hemoglobin, the latter enabling
exquisite images of the vasculature to be acquired.3 However,
many cells and tissues are weakly absorbing at visible and near-
infrared wavelengths and thus require labeling with exogenous
contrast agents to provide PA image contrast. Such exogenous
contrast agents would ideally have a strong extinction
coeﬃcient, good photostability, high thermodynamic eﬃciency,
narrow absorption spectrum, and low toxicity, and be
selectively retained at the target while being rapidly cleared
from the rest of the body. Most importantly, the ideal
exogenous contrast agent would absorb in the near-infrared
range (NIR), i.e., 620−920 nm. This range is known as the
optical window of tissue, due to the low absorption of water
and hemoglobin in this region.
Various types of contrast agents may be used and a range of
small molecule NIR dyes is already available; however these
have several disadvantages. These include modest molar
extinction coeﬃcients, photoinstability after prolonged irradi-
ation, and a tendency to aggregate. Moreover, their small size
contributes to a rapid systemic clearance, reducing the
likelihood of target delivery and retention.2 Nanoparticle
contrast agents, which include gold nanorods (GNR) and
single walled carbon nanotubes (SWCNT), have several
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advantages: they exhibit very high extinction coeﬃcients, the
absorption wavelength may be tuned, they can carry additional
cargoes such as therapeutic drugs, and they accumulate in
targets such as tumors via the EPR eﬀect.4 However, concerns
about high cost, poor biodegradability, and potential toxicity of
gold- and carbon-based nanoparticles have recently prompted
research into other types of nanoparticle contrast agents.
Semiconducting polymer nanoparticles (SPNs) have recently
been developed; these are formulated from π-conjugated
organic semiconductors along with amphiphilic polymers or
surfactants to produce nanoparticles that are stable in aqueous
solutions. The enhanced photostability, high quantum yield,
and biocompatibility5 of the resulting SPNs has already led to
their use in various biological imaging and biosensing
applications.6,7 It has recently been demonstrated that SPNs,
formulated using π-conjugated organic semiconductors with
high NIR absorption, can be used as PA contrast agents.8−11
These SPNs have been reported to have signiﬁcantly stronger
signal per mass, and better photostability, than GNR or SWNT;
preliminary studies have shown these to be eﬀective for in vivo
imaging of reactive oxygen species8 and brain vascular
imaging.11
Clearly a major advantage of using SPNs as PA contrast
agents would be the potential to tune the PA properties of
these nanoparticles by using NIR π-conjugated organic
semiconductors with diﬀerent structural and spectral properties.
However, to date only a limited selection of suitable polymers
has been investigated, and as a result, the previously reported
SPNs have UV absorption peaks at a correspondingly limited
set of single wavelengths. Of particular interest is the synthesis
of high extinction coeﬃcient, narrow band gap conjugated
polymers allowing for eﬃcient generation of a PA signal in the
near-infrared region of the electromagnetic spectrum.
In this paper, we report the formulation and full character-
ization of a novel series of π-conjugated organic semiconductor
nanoparticles with outstanding properties for the use as
contrast agents for in vivo PA imaging. These nanoparticles
exhibit strong absorption in the NIR, with good PA signal
generation eﬃciencies and photostability. Their extinction
coeﬃcient is up to three times higher compared to similar
particles previously reported.8−11 In addition, the absorption
maximum of the novel nanoparticles is conveniently located in
the spectral region of low absorption of chromophores within
human tissue, making the particles well suited as contrast
agents for PA imaging. Furthermore, the novel family of π-
conjugated organic semiconductors that have been used to
formulate the SPNs can be readily tuned to a variety of NIR
wavelengths by small variations in the electron richness or
deﬁciency of the component monomers. This has allowed us, in
this work, to produce a family of SPN PA contrast agents that
can be tuned to diﬀerent wavelengths in the biologically
relevant NIR window.
■ RESULTS AND DISCUSSION
Preparation and Characterization of NIR π-Conju-
gated Organic Semiconductors. We previously reported
the synthesis of a conjugated polymer12 with an extremely
narrow band gap, the origin of which was the exceptional
electron accepting properties of the little used 2,9-dihydroxy-
7,14-di(thiophen-2-yl)-diindolo[3,2,1-de:3′,2′,1′-ij][1,5]-
naphthyridine-6,13-dione (INDT) core. Using this novel
chromophore a family of indigoid ultranarrow band gap
materials with excellent solution processability were synthesized
by copolymerization with monomers of varying electron
richness or deﬁciency.13 The four polymers which were chosen
for this study were the previously reported PCPDTBT 16−12
and the indigoid π-conjugated organic semiconductors INDT-T
2, INDT-S 3, and INDT-BT 4 (Figure 1).
All of these display band-gaps in the region of ∼1.2 eV,
making them ideal candidates for PA imaging in comparison to
other wider band gap materials such as PCPDTBT 1. In
addition, the absorption maxima of INDT-T 2, INDT-S 3, and
INDT-BT 4 are signiﬁcantly red-shifted in comparison to
PCPDTBT 1 (Figure 2).
Formulation and Characterization of SPNs. Two
approaches are currently used to formulate SPNs, nano-
precipitation, and mini-emulsion.6,7 In the nanoprecipitation
approach, the π-conjugated organic semiconductor is dissolved
in a “good” solvent and then added to an excess of a “poor”
solvent under ultrasonic dispersion; the change in solvent
polarity results in the aggregation of the polymers. The two
solvents must be miscible with each other, such as acetone/
water, THF/water, or ethanol/water. This is then followed by
evaporation of the organic solvent in an inert atmosphere to
give the SPNs in an aqueous solution. However, for organic
semiconductors that are not soluble in organic solvents that are
miscible with water, the mini-emulsion approach is employed.
In this method, the organic semiconductor is dissolved in a
solvent such as chloroform, which is immiscible with water, and
Figure 1. Structures of the π-conjugated organic semiconductors
PCPDTBT 1, INDT-T 2, INDT-S 3, and INDT-BT 4.
Figure 2. UV−visible spectra of the π-conjugated organic semi-
conductors PCPDTBT 1, INDT-T 2, INDT-S 3, and INDT-BT 4 in
chlorobenzene.
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added to a dispersion of surfactant in water under ultrasonic
dispersion. In this work we aimed to coencapsulate the π-
conjugated organic semiconductors with a saturated lipid, 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) (Figure 3),
as it has been previously shown that varying the particle surface
by using diﬀerent lipids has little eﬀect on the PA properties of
the resulting SPNs.9
Using the nanoprecipitation method, as previously reported,8
an aqueous solution of SPN1 was successfully prepared from
PCPDTBT and DPPC. However, polymers INDT-T, INDT-S,
and INDT-BT are not fully soluble in THF, and for these
polymers the mini-emulsion approach was used to give aqueous
solutions of SPN2, SPN3, and SPN4 (Table 1). The
nanoparticles prepared were between 120 and 160 nm in
diameter. This makes them ideally sized for cancer imaging, as
nanoparticles between 100 and 200 nm in size accumulate in
tumors14 through a combination of leaky tumor endothelium
and ineﬀective lymphatic drainage, a phenomenon known as
the enhanced permeability and retention eﬀect (EPR). The
measured ζ-potentials varied between −25.6 mV and −37.8
mV.
The PA properties of the aqueous solutions of the
nanoparticles SPN1−4 were determined using a custom
designed PA spectroscope.15 PA amplitude and PA derived
extinction spectra were generated over the 450−950 nm
spectral range and the thermalization eﬃciency (the eﬃciency
for the conversation from absorbed light to heat) was calculated
as described previously.15 A UV/vis/NIR spectrophotometer
(PerkinElmer 750s) was used to obtain the absorbance
spectrum of the nanoparticles for comparison with the PA
spectra. The resulting spectra with the measured extinction
coeﬃcient are shown in Figure 4a and values of λmax and ε
summarized in Table 1. The nanoparticles did not display any
detectable ﬂuorescence as would be expected from their
extremely narrow band gap (due to the energy gap law)
indicating that radiative decay is not a loss mechanism in these
materials.
In order to investigate the photostability of the nanoparticles
freshly prepared samples of SPN1−4 were irradiated with 18 ×
103 laser pulses, while the PA amplitude was recorded every
minute, averaging over 100 signals. For these experiments the
laser output was tuned to the wavelength of peak absorption of
the individual samples. In the case of SPN1 the peak absorption
wavelength cannot be generated by the laser used and therefore
the laser was tuned to 750 nm for the bleaching experiment.
For comparison two common organic dyes (cresyl violet and IR
820) were analyzed for their photostability under the same
conditions. The results of the photobleaching experiments are
shown in Figure 4b, showing high photostability of all of the
nanoparticles. Irrespective of the formulation method, nano-
particles of consistent and similar size and zeta potential were
formed, with strong absorption in the NIR, high photostability,
and thermalization eﬃciencies of 100%. The latter indicates
that the nanoparticles exhibit negligible radiative relaxation with
a quantum yield close to zero. Due to the superior extinction
coeﬃcient (253 cm−1 L g−1) and the spectral position of the
wavelength of peak absorption at 800 nm, SPN4 was chosen for
further in vivo experiments.
In Vitro Cytotoxicity Assessment. In vitro cytotoxicity of
SPN1, SPN2, SPN3, and SPN4 was evaluated in the 293T
human embryonic kidney cell line. Cells were exposed to a
range of concentrations (0−25 μg/mL) of the nanoparticles for
24 h, and cell viability was determined by the MTT assay.
There was no signiﬁcant eﬀect on cell viability with any of the
nanoparticles at the investigated range of concentrations
(Figure 5), indicating that the nanoparticles are biocompatible
in vitro.
In Vivo PA Imaging. In vivo PA images were acquired of a
bolus of SPN4, injected subcutaneously into the ﬂank of a
mouse, as described in the Experimental Procedures section.
Figure 6 shows a selection of PA images at 5 wavelengths out of
10 diﬀerent wavelengths acquired, of the same ﬁeld of view (14
mm × 14 mm × 6 mm), before (Figure 6a) and after injection
of SPN4 (Figure 6b), revealing the presence of the nano-
particles after injection. The images in Figure 6b were acquired
sequentially, within 1.5 h after injection. At 600 nm, blood
provides stronger optical absorption than SPN4, resulting in
relatively low image contrast of the nanoparticles, whereas at
800 nm SPN4 has a stronger optical absorption compared to
the absorption of blood. The contrast from SPN4 was still
visible at long wavelengths (1000 nm), against the background
of blood and increasing absorption water. The visible areas of
higher contrast within the injected bolus of Figure 6b are due to
Figure 3. Schematic showing the preparation of the SPNs by
nanoprecipitation or mini-emulsion approaches.
Table 1. Physical and Spectroscopic Properties of the Four π-Conjugated Organic Semiconductors and the Semiconducting
Polymer Nanoparticles SPN1−4 Formulated from Them
polymer λmax
a [nm] Mn [kDa] Mw/Mn SPN diameter [nm] PDI ζ potential [mV] λmax [nm] ε [cm
−1 g L−1]
PCPDTBT 1 709 6 1.3 SPN1 145 0.2 −37.8 700 83
INDT-T 2 802 20 4.0 SPN2 159 0.25 −25.6 780 79
INDT-S 3 844 25 3.3 SPN3 120 0.23 −29.8 790 139
INDT-BT 4 826 40 3.0 SPN4 160 0.25 −31.0 800 253
aλmax measured in chlorobenzene solution.
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aggregation of SPN4 during subcutaneous injection. Figure 6c
shows the in vivo wavelength dependence of SPN4, derived
from the in vivo images, some of which are shown in Figure 6b.
These data points were obtained by integrating the image
intensity in 3D over the regions corresponding to the
nanoparticles normalized by the integrated image intensity of
the ﬁrst slice of the 3D image where the particles are not
present. This normalization step corrects for the diﬀerence in
pulse energy output of the laser at the diﬀerent wavelengths
although it does not correct for spectral variations in the
subsurface ﬂuence at the nanoparticle bolus. As evidenced by
the close agreement of the in vivo and in vitro PA spectra in
Figure 6c, these variations are small due to the superﬁcial
location of the bolus. Also shown in Figure 6c are the
normalized speciﬁc absorption coeﬃcient spectra of oxy-
hemoglobin (HbO2) and deoxyhemoglobin (HHb). These
results illustrate the wavelength-dependent diﬀerential contrast
between the vasculature and SPN4, which can be used to
unambiguously discriminate the presence of SPN4 in vivo.
■ CONCLUSIONS
In this paper we describe the chemistry, formulation, and PA
characteristics of a novel series of semiconducting polymer
nanoparticles which we have developed as PA contrast agents.
These are based on novel indigoid π-conjugated organic
semiconductors with a high extinction coeﬃcient, narrow band
gap, and with absorption maxima located in the near-infrared in
the “optical window” of low absorption of endogenous
chromophores within human tissue. These polymers were
coformulated with DPPC to give stable nanoparticles of
Figure 4. (a) Extinction spectra of SPN1−4, measured using the PA spectroscope (normalized PA amplitude spectra: hollow markers; PA derived
extinction spectra: solid markers) and spectra obtained using a spectrophotometer (lines). (b) Photostability of SPN1−4 at concentrations of ∼40
mg L−1, cresyl violet (700 μM), and IR 820 (230 μM) under continuous irradiation with pulsed laser light with a ﬂuence of ∼2 mJ cm−2.
Wavelengths were chosen corresponding to the wavelength of peak absorption of the individual nanoparticles, except for SPN1 where 750 nm was
chosen as the excitation wavelength.
Figure 5. Evaluation of the cytotoxicity in 293T human embryonic kidney cells of SPN1, SPN2, SPN3, and SPN4 as determined using the MTT
assay following a 24 h incubation period (data presented as mean ± SD).
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consistent size and zeta potential, good photoacoustic signal
generation eﬃciencies, high photostability, and extinction
coeﬃcients up to three times higher than previously reported
SPN. Moreover, our studies demonstrated no signiﬁcant in vitro
cytotoxicity in human embryonic kidney cells. This is in line
with previous reports indicating that similar semiconducting
polymer nanoparticles have low toxicity,5,9,10 making these
tunable nanoparticles excellent candidates for in vivo imaging,
and suggesting that other organic semiconductors should also
be investigated for such applications.
In preliminary in vivo experiments we have demonstrated
that at 800 nm the best of the nanoparticles, SPN4, provides a
signiﬁcantly stronger signal than adjacent blood vessels,
allowing us to unambiguously image the presence of SPN4
relative to the vasculature. We have also shown that small
modiﬁcations to this series of π-conjugated organic semi-
conductors allows us to tune the absorption maxima of the
various SPN to diﬀerent wavelengths. This will in turn allow
the SPN to be tuned to wavelengths where relatively
inexpensive lasers are available. It will also make it possible to
select SPNs which are optimized for greatest tissue penetration,
which might be diﬀerent for diﬀerent tissue, organs, and
pathologies. Finally, the tuneability of these SPN will eventually
enable multiplexing, with two or more SPN, each with a
diﬀerent absorption spectrum and targeted to diﬀerent
receptors being used to visualize multiple targets simulta-
neously. While the spectral characteristics of the reported SPN
will be suﬃcient for most applications, given the broad spectral
features of endogenous chromophores, for applications
requiring multiple contrast agents with diﬀerent spectra it will
be highly desirable to reduce the breadth of the spectrum and
make the onset of the absorption steeper. These are current
issues in the general ﬁeld of organic electronics, and this
suggests an important avenue for future research in the area of
semiconducting polymer nanoparticles. Ultimately, for these
SPN to be eﬀective as contrast agents for preclinical and clinical
use, issues of biocompatibility, stability, and validation of
targeting must also be studied,16 and in future work we will
address these issues.
■ EXPERIMENTAL PROCEDURES
Chemicals. 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC) was purchased from Avanti Lipids, USA. Poly-
[cyclopentadithiophene-alt-benzothiadiazole] (PCPDTBT 1)
was purchased from Sigma-Aldrich. All other chemicals were
obtained from Sigma-Aldrich unless otherwise stated. The
synthesis and characterization of INDT-T 2, INDT-S 3, and
INDT-BT 4 have been reported elsewhere,13 and are included
in the Supporting Information.
Preparation of SPNs. SPN1 was prepared via nano-
precipitation using PCPDTBT (Mw 20 872 g mol
−1) which was
dissolved in THF at a concentration of 0.25 g L−1. The
formation of nanoparticles using the nanoprecipitation method
was initiated via the rapid injection, with a syringe, of 1 mL of
the polymer solution into 9 mL of deionized water under
continuous sonication using a probe sonicator (Q125; 3 mm tip
diameter; QSonica, US) set to 6W RMS for 30 s. Subsequently,
1 mL of a solution of 1,2-dipalmitoyl-sn-glycero-3-phosphocho-
line (DPPC) in THF:water (2:3) was injected to the sonicated
solution in order to stabilize the nanoparticles. The mixture was
kept under sonication for an additional 1 min at 6W RMS
before the sonicator-tip was removed from the mixture. For the
ﬁnal step the organic solvent was evaporated via heating the
resulting solution in a water-bath to 45 °C and bubbling
nitrogen through it. After about 2 h the resulting suspension of
SPN1 was then ﬁltered through a 0.22 μm poly(ether sulfone)
syringe driven ﬁlter (Merck Millipore, US) and washed three
times with deionized water using centrifugal ﬁlters with an
MWCO of 30k Da (Merck Millipore, US) under centrifugation
at 4000 rpm for 3 min at 4 °C. After the washing step the
nanoparticles were resuspended in deionized water using an
ultrasonication bath. The resulting nanoparticles appear blue
when in suspension and were analyzed using DLS, TEM,
spectrophotometer, and PA spectroscopy.
Polymers based on INDT-x have little or low solubility in any
other organic solvent than dichloromethane and chloroform.
Consequently, the mini-emulsion approach was applied for the
preparation of SPN2−4. Therefore, 2.5 mg of DPPC were
dispersed in 2.5 mL of deionized water and vortexed for 1 min
before the mixture was sonicated for about 3 min in a sonicator
bath. The polymers (INDT-T 2, INDT-S 3, and INDT-T 4)
were dissolved in CHCl3 to obtain a ﬁnal concentration of 0.6 g
L−1 of each of the polymers in the organic solvent. To ensure
the full solvation of the polymers, each of the polymer mixtures
was heated to reﬂux to obtain dark blue solutions.
Subsequently, 160 μL of one of the dissolved polymers was
pre-emulsiﬁed in the aqueous surfactant mixture by stirring
Figure 6. Multiwavelength in vivo photoacoustic showing spectral
dependence of INDT-BT nanoparticles (SPN4) and vasculature:
Subsample of photoacoustic images (a) before and (b) after
subcutaneous injection of a 10 μL solution, containing 1.6 μg of
SPN4, into the ﬂank of a SCID mouse. x-y MIPs (top rows, area 14 ×
14 mm2) and y-z MIPs (bottom rows, area 14 × 6 mm2) acquired at
diﬀerent excitation wavelengths are shown. (c) Normalized wavelength
dependence of SPN4 absorption from the in vivo photoacoustic images
shown in (b), normalized in vitro PA spectra of SPN4 and the
normalized speciﬁc absorption of oxyhemoglobin and deoxyhemoglo-
bin.
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with a magnetic stirrer for 5 min at 1000 rpm. Next, the
emulsion was subjected to high power sonication (10W RMS)
for 30 s using a probe sonicator. After formation of the
miniemulsion, the power output of the probe sonicator was
reduced to 5W RMS and the mixture subjected to cycles of 30 s
sonication and 10 s of resting with the probe sonicator turned
oﬀ. After about 5 min, the opaque solution began to clear,
resulting in a clear colored solution. Then, the solution was
placed in a water-bath of 60 °C for about 2 h in order to
evaporate the remaining organic solvent. Lastly, the aqueous
suspension of polymeric nanoparticles was ﬁltered through a
0.22 μm poly(ether sulfone) syringe driven ﬁlter and washed
three times with deionized water using centrifugal ﬁlters with an
MWCO of 30 kDa under centrifugation at 4000 rpm for 3 min
at 4 °C. After the washing step the nanoparticles were
resuspended in deionized water using an ultrasonication bath.
Polymer and Nanoparticle Characterization. UV−vis
spectra were recorded on a PerkinElmer Lambda 950
spectrophotometer between 400 and 1100 at 2 nm steps.
Solution spectra were recorded in chlorobenzene and thin-ﬁlms
were spin-coated at 10 000 rpm for 30 s onto glass substrates
using polymer solutions of 5 mg/mL in chlorobenzene.
Number-average (Mn) and weight-average (Mw) molecular
weights of all four polymers were determined using gel
permeation chromatography in chlorobenzene at 80 °C against
a polystyrene standard using an Agilent Technologies 1200
series spectrometer. The size and zeta potential of nanoparticles
SPN1−4 were measured using a Malvern Zetasizer Nano
(ZSZEN3600, Malvern Instruments Ltd., UK), using a He−Ne
laser 633 nm, Max 4 mW for excitation and a detection angle of
173°.
PA Spectroscopy. The PA spectroscope15 used for the
characterization of the nanoparticles consists of a 30 Hz tunable
ﬁber-coupled Nd:YAG pumped OPO laser (Spitlight 600,
InnoLas Laser GmbH, Krailling, Germany) with a pulse-to-
pulse tuning capability as the excitation source and a PVDF
transducer with a −3 dB bandwidth of <20 MHz. Irradiating a
sample contained in a Perspex sample cuvette generates
acoustic signals which are detected by the PVDF transducer,
ampliﬁed and ﬁnally digitized using a data-acquisition card. As
described previously,15 PA spectra were generated by scanning
the excitation laser in the spectral region between 450 and 950
nm in 5 nm step increments and acquiring the PA signals at
each wavelength step. The PA amplitude spectrum was
obtained from this data by plotting the normalized peak
positive amplitudes of the detected PA signals as a function of
wavelength to provide a relative spectrum. The extinction
coeﬃcient spectra were obtained from the same PA data set by
ﬁtting an exponential to the initial compressive part of the
detected PA signals to recover the absorption coeﬃcient μa.
The extinction coeﬃcient was then obtained by dividing μa by
the concentration. For an estimate of the concentration of the
nanoparticles prepared, the ratio of the weight of the polymers
injected to the aqueous phase during the procedure and the
ﬁnal volume of the nanoparticle solution was used.
In Vitro Cytotoxicity of Nanoparticles. The human
embryonic kidney cell line, 293T, was cultured in Dulbecco’s
Modiﬁed Eagle Medium (DMEM) containing 10% fetal bovine
serum at 37◦ C in a humidiﬁed environment, containing 5%
CO2. In vitro cytotoxicity of the nanoparticles was evaluated by
the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide] cell viability assay.
Brieﬂy, 5 × 104 cells were seeded in 96-well plates and
incubated overnight. Cells were then exposed to a range of
concentrations (0−25 μg/mL) of SPN1, SPN2, SPN3, and
SPN4 and for a period of 24 h; following which cells were
washed with PBS and incubated with drug-free medium for 3
days. The MTT reagent (5 mg/mL) was then added to each
well and cells were incubated for 2 h, followed by the addition
of ethanol:DMSO (1:1) solution and optical density (OD) was
measured at 540 nm. The percentage of viable cells was
calculated as follows:
=
×
Cell Viability(%) OD of treated cells
/OD of untreated cells) 100
540nm
540nm
In Vivo PA Imaging. A detailed description of the PA
tomography system used for the in vivo experiments can be
found elsewhere.17 Brieﬂy, the system comprises a 50 Hz
tunable ﬁber-coupled Q-switched Nd:YAG pumped OPO laser
(premiScan, GWU and Quanta-Ray PRO-270, Newport
Spectra Physics) as an excitation source and a Fabry−Perot
based ultrasound detection system with a −3 dB bandwidth of
22 MHz. In backward mode operation, photoacoustic waves are
generated in tissue by the absorption of the nanosecond optical
pulses provided by the OPO laser system. These waves are
mapped in 2-D by raster-scanning a cw focused interrogation
laser beam across the sensor and recording the acoustically
induced modulation of the reﬂectivity at each scan point. A 12-
week-old SCID mouse was anaesthetized using isoﬂurane in
oxygen [4% (v/v) at a ﬂow rate of 2 L/min for induction and
1.5% (v/v) at a ﬂow rate of 1 L/min for maintenance] before
being placed on a custom designed cradle on the scanner.
Acoustic coupling between the mouse and the sensor was
maintained by ultrasound gel applied to the surface of the
mouse skin. PA signals of the vasculature were acquired at ten
wavelengths between 600 and 1000 nm, including the peak
absorption wavelength of SPN4 at 800 nm, before a
subcutaneous injection of a 10 μL solution containing 1.6 μg
of SPN4 into the right ﬂank. PA signals were then acquired at
the same wavelengths, beginning 10 min after injection. The
placing of the mouse on a cradle ensured that same ﬁeld of view
(14 × 14 mm area) was imaged pre- and post-injection of
SPN4. Data acquisition at each wavelength took approximately
7 min. The last of the PA signals was therefore completed
within 1.5 h after injection of SPN4. Three-dimensional
photoacoustic images were reconstructed from the detected
PA signal waveforms, using a time reversal based algorithm
which includes compensation for acoustic attenuation.18,19
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DMEM, Dulbecco’s Modiﬁed Eagle Medium; DPPC, 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine; EPR, enhanced per-
meability and retention; GNR, gold nanorods; INDT, 2,9-
dihydroxy-7,14-di(thiophen-2-yl)-diindolo[3,2,1-de:3′,2′,1′-ij]-
[1,5]naphthyridine-6,13-dione; MTT, 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide; NIR, near-infrared range;
PA, photoacoustic; PBS, phosphate-buﬀered saline; PCPDTBT,
poly[cyclopentadithiophene-alt-benzothiadiazole; SPN, semi-
conducting polymer nanoparticles; SWCNT, single walled
carbon nanotubes
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